Acarizax
Allergen extract administered under the tongue (sublingual) to treat house dust mite induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis), in people 18 through 65 years of age.
Acarizax provides patients an alternative treatment to allergy shots to help address their symptoms.
House dust mite allergies are a reaction to tiny bugs that are commonly found in house dust. Dust mites are too small to be seen without a microscope. They are found in bedding, upholstered furniture and carpeting. Individuals with house dust mite allergies may experience a cough, runny nose, nasal itching, nasal congestion, sneezing, and itchy and watery eyes.
Acarizax exposes patients to house dust mite allergens, gradually training the immune system in order to reduce the frequency and severity of nasal and eye allergy symptoms. It is a once-daily tablet, taken year round, that rapidly dissolves after it is placed under the tongue. The first dose is taken under the supervision of an Allergist with experience in the diagnosis and treatment of allergic diseases. The patient is to be observed for at least 30 minutes for potential adverse reactions. Provided the first dose is well tolerated, patients can then take Acarizax at home. It can take about 8 to 14 weeks of daily dosing for the patient to begin to experience a noticeable benefit.
The most commonly reported adverse reactions were nausea, itching in the ears and mouth, and swelling of the lips and tongue.